Clinical effects of tranexamic acid on bleeding tendency due to fibrinolytic activation of AL amyloidosis

We report a case where tranexamic acid, which is an antifibrinolytic agent, was used to effectively treat bleeding tendency in a patient with immunoglobulin light chain (AL) amyloidosis. A male patient in his 80s without a history of bleeding disorders was admitted to our hospital for the examinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Gaku, Mori, Hideki, Mori, Takahiro, Sakaki, Chika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533652/
https://www.ncbi.nlm.nih.gov/pubmed/37751987
http://dx.doi.org/10.1136/bcr-2022-254483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533652/
https://www.ncbi.nlm.nih.gov/pubmed/37751987
http://dx.doi.org/10.1136/bcr-2022-254483

Ejemplares similares